ストックスクリーナーアプリを入手
5.68
3.73%
-0.22
前日終値:
$5.90
開ける：
$5.835
24時間の取引高:
8,130
Relative Volume:
0.15
時価総額：
$170.70M
収益：
$8.98M
当期純損益:
$-31.39M
株価収益率:
-4.2388
EPS:
-1.34
ネットキャッシュフロー:
$-24.83M
1週間 パフォーマンス:
+0.71%
1か月 パフォーマンス:
-5.33%
6か月 パフォーマンス:
-19.43%
1年 パフォーマンス:
-47.84%
1日の値動き範囲:
$5.65
$5.905
1週間の範囲:
$5.54
$6.0404
52週間の値動き範囲:
$3.895
$11.42
Profound Medical Corp Stock (PROF) Company Profile
名前
Profound Medical Corp
セクター
電話
647-476-1350
住所
2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON
PROF を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PROF
Profound Medical Corp
|
5.68 | 177.31M | 8.98M | -31.39M | -24.83M | -1.34 |
|
ABT
Abbott Laboratories
|
126.54 | 218.59B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.14 | 157.13B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
403.53 | 151.59B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.94 | 118.29B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
80.00 | 44.46B | 5.69B | 4.15B | 623.10M | 6.95 |
Profound Medical Corp Stock (PROF) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-23 | 開始されました | Lake Street | Buy |
| 2024-07-16 | アップグレード | Stifel | Hold → Buy |
| 2023-11-28 | 開始されました | Stifel | Hold |
| 2023-08-04 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2023-03-21 | ダウングレード | Jefferies | Buy → Hold |
| 2020-09-15 | 開始されました | Jefferies | Buy |
すべてを表示
Profound Medical Corp (PROF) 最新ニュース
Why Profound Medical Corp. stock attracts strong analyst attentionMarket Trend Watch - Metal.it
Profound Medical Corp. Stock Analysis and ForecastPhenomenal capital gains - PrintWeekIndia
(PRN) Technical Patterns and Signals (PRN:CA) - news.stocktradersdaily.com
Should I buy Profound Medical Corp. stock before earningsFree Investment Timing Strategies - jammulinksnews.com
What analysts say about Profound Medical Corp. stockConsistent wealth multiplication - Autocar Professional
Profound Medical to Announce Q2 2025 Financial Results - TipRanks
Profound Medical to Release Second Quarter 2025 Financial Result - GuruFocus
Profound Medical to Release Second Quarter 2025 Financial Results on August 14Conference Call to Follow - The Manila Times
Profound Medical to Release Second Quarter 2025 Financial Results on August 14 – Conference Call to Follow - Toronto Star
Is Profound Medical Corp. stock a growth or value playUnprecedented growth rates - jammulinksnews.com
Is Profound Medical Corp. a good long term investmentBreakneck growth rates - jammulinksnews.com
(PRN) Stock Market Analysis (PRN:CA) - news.stocktradersdaily.com
What makes Profound Medical Corp. stock price move sharplyWeekly Double Return List - Newser
What drives Profound Medical Corp. stock priceConsistent triple returns - jammulinksnews.com
MARA Stock Analysis and ForecastMarket-leading growth rates - Jammu Links News
What drives ONIT stock priceHigh-yield investments - Jammu Links News
Why Omega Flex Inc. stock is on top investor watchlistsDaily Stock Radar - Newser
(PRN) Trading Report (PRN:CA) - news.stocktradersdaily.com
How Profound Medical Corp. stock performs during market volatilityFree Stock Trading Signals - Newser
Profound Medical: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (PRN) - The Globe and Mail
(PRN) Dynamic Trading Report (PRN:CA) - news.stocktradersdaily.com
Profound Medical Completes First Commercial BPH Treatment With New TULSA-AI Volume Reduction Module - MSN
(PRN) Trading Strategy and Analysis (PRN:CA) - news.stocktradersdaily.com
Top Companies in Radiation Therapy Devices (Jul, 2025) - Tracxn
Profound Medical's TULSA-AI: Revolutionizing BPH Treatment and Market Expansion - AInvest
(PRN) Stock Trading Blueprint (PRN:CA) - news.stocktradersdaily.com
How To Trade (PRN) (PRN:CA) - news.stocktradersdaily.com
Global Uterine Fibroids Treatment Devices Market is - GlobeNewswire
(PRN) Advanced Equity Analysis (PRN:CA) - news.stocktradersdaily.com
Following a 26% decline over last year, recent gains may please Profound Medical Corp. (TSE:PRN) institutional owners - simplywall.st
Profound Medical (NASDAQ:PROF) Shares Up 17.4% – What’s Next? - Defense World
Regulatory Affairs in Life Sciences - Fasken
Profound Medical (PROF) Advances BPH Treatment with New Module | - GuruFocus
Profound Medical announces first commercial BPH treatment using TULSA-AI - TipRanks
Profound Medical (PROF) Advances BPH Treatment with New Module | PROF Stock News - GuruFocus
Profound Medical Brief: Announcing First Commercial BPH Patient Treatment Using TULSA-PRO with TULSA-AI Volume Reduction - MarketScreener
Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction - Yahoo Finance
(PRN) Trading Performance and Risk Management (PRN:CA) - news.stocktradersdaily.com
Profound Medical Corp (PROF) 財務データ
収益
当期純利益
現金流量
EPS
1.27%
大文字化:
|
ボリューム (24 時間):